Search research articles
Contact Us
Filters
Showing results (271-280 of 348) with videos related to
Page
of 35
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 11, 2008
Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS)
Richard J Gralla, Martin J Edelman, Frank C Detterbeck, et al.
Cancer Chemotherapy and Pharmacology
|
October 27, 1998
High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically
P N Lara, D R Gandara, G T Wurz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 6, 2017
Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance)
Maria Q Baggstrom, Mark A Socinski, Xiaofei F Wang, et al.
The Annals of Thoracic Surgery
|
August 30, 2008
Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer
Martin J Edelman, Mohan Suntharalingam, Whitney Burrows, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2012
Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial
Pasi A Jänne, Xiaofei Wang, Mark A Socinski, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 7, 2014
Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer
Joe J Stephenson, John Nemunaitis, Anil A Joy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2008
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203
Martin J Edelman, Dee Watson, Xiaofei Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2007
Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapy
Johan Vansteenkiste, Primo N Lara, Thierry Le Chevalier, et al.
Scientific Reports
|
April 20, 2025
Winter activity of tricolored bats in aboveground and subterranean hibernacula in the southeastern USA
Susan C Loeb, William C Bridges, Eric A Winters, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 27, 2015
Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non-Small-Cell Lung Cancer
Helen Chow, Martin J Edelman, Giuiseppe Giaccone, et al.
Page
of 35
Search research articles
Search
Showing results (271-280 of 348) with videos related to
Sort By:
Page
of 35
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 11, 2008
Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS)
Richard J Gralla, Martin J Edelman, Frank C Detterbeck, et al.
Cancer Chemotherapy and Pharmacology
|
October 27, 1998
High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically
P N Lara, D R Gandara, G T Wurz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 6, 2017
Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance)
Maria Q Baggstrom, Mark A Socinski, Xiaofei F Wang, et al.
The Annals of Thoracic Surgery
|
August 30, 2008
Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer
Martin J Edelman, Mohan Suntharalingam, Whitney Burrows, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2012
Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial
Pasi A Jänne, Xiaofei Wang, Mark A Socinski, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 7, 2014
Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer
Joe J Stephenson, John Nemunaitis, Anil A Joy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2008
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203
Martin J Edelman, Dee Watson, Xiaofei Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2007
Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapy
Johan Vansteenkiste, Primo N Lara, Thierry Le Chevalier, et al.
Scientific Reports
|
April 20, 2025
Winter activity of tricolored bats in aboveground and subterranean hibernacula in the southeastern USA
Susan C Loeb, William C Bridges, Eric A Winters, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 27, 2015
Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non-Small-Cell Lung Cancer
Helen Chow, Martin J Edelman, Giuiseppe Giaccone, et al.
Page
of 35